As of Monday this week (until December 12), you can vote (once a day) for The “New” Prostate Cancer InfoLink as one of the best health care blog sites on Healthline’s Annual Best Health Blog Contest! Check it out.

As of now we have one vote in … but there don’t seem to be many people voting yet, so if we could get a couple of hundred in … :O)

Thanks for the vote of confidence (someone)

We are pleased to be able to announce that someone has nominated The “New” Prostate Cancer InfoLink as a candidate for Healthline’s Annual Best Health Blog Contest! … READ MORE …

Are advocacy organizations influenced by funding from pharmaceutical companies?

A new commentary posted today on the Medscape web site addresses financial support for the activities of patient advocacy organizations by biopharmaceutical companies. … READ MORE …

The cost and the effectiveness of genomic testing for prostate cancer risk

As regular readers will be well aware, there are now several different tests available that can be used to assess risk for low- and very low-risk forms of prostate cancer at time of diagnosis (as opposed to clinically significant forms that need early treatment). … READ MORE …

Upcoming events from Prostate Cancer International

Just a quick note about two new and upcoming events from Prostate Cancer International — a live, patient-focused meeting in Florida and our next CureTalks session:

  • On November 29, 2016, at 6 p.m. Eastern time, we will hold our next CureTalk on prostate cancer, discussing the evolving option of focal laser ablation at a treatment for localized prostate cancer with Dr. Ara Karamanian of the Prostate Laser Center in Houston, TX. Click here to learn more and to register.
  • On March 4, 2017, from 9:00 am to 4 p.m., we are coordinating a one-day meeting for prostate cancer patients and caregivers entitled “Prostate Cancer TODAY: Living Well; Choosing Wisely,” to be held at the Charlotte Harbor Event and Conference Center at Punta Gorda, Florida. Click here to learn more and to register.

Pardon the slight hiatus over the past 24 hours

We have solved the problem … even if we haven’t quite been able to work out why it became a problem in the first place!

91 percent of Swedish men diagnosed with very low-risk prostate cancer now start on active surveillance

According to a new paper, just published in JAMA Oncology, the vast majority of Swedish men diagnosed with very low- and low-risk prostate cancer are now being initially managed on active surveillance. … READ MORE …